United Drug Co. v. Theodore Rectanus Co.

248 U.S. 90, 39 S. Ct. 48, 63 L. Ed. 141, 1918 U.S. LEXIS 1694
CourtSupreme Court of the United States
DecidedDecember 9, 1918
Docket27
StatusPublished
Cited by593 cases

This text of 248 U.S. 90 (United Drug Co. v. Theodore Rectanus Co.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United Drug Co. v. Theodore Rectanus Co., 248 U.S. 90, 39 S. Ct. 48, 63 L. Ed. 141, 1918 U.S. LEXIS 1694 (1918).

Opinion

Mr. Justice Pitney

delivered the opinion of the court.

This was a suit in equity brought September 24, 1912, in the United States District Court for the Western District of Kentucky, by the present petitioner, a Massachusetts corporation, against the respondent, a Kentucky corporation, together with certain individual, citizens of the latter State, to restrain infringement of trade-mark and unfair competition.

The District Court granted an injunction against the corporation defendant pursuant to the prayer of the bill. 206 Fed. Rep. 570. The Circuit Court of Appeals reversed the decree and remanded the cause with directions to dismiss the bill. 226 Fed. Rep. 545. An appeal was allowed by one of the judges of that court, and afterwards we allowed a writ of certiorari. Pursuant to a stipulation, the transcript of the record filed for the purposes of the-appeal was treated as a return to the writ. Under § 128, Judicial Code, as amended by Act of January 28, 1915, c. 22, § 2, 38 Stat. 803, the appeal must be dismissed, and the cause will be determined on the writ of certiorari.

*94 The essential facts are as follows: About the year 1877 Ellen M. Régis, a resident of Haverhill, Massachusetts, began to compound and distribute in a small way a prep-; a'ration for medicinal use in cases of dyspepsia' and some other ailments, to which she applied’ as a distinguishing . name the word “Rex” — derived from her surname. The word was put upon the boxes and packages in which the medicine was placed upon the market, after the usual maimer of a trade-mark. At first alone, and afterwards in. partnership with her son under the firm name of “E. M. Regis & Company,” she continued the business on a mod- ' est scale; in 1898 she recorded the word “Rex” as á trademark under the laws of Massachusetts (Acts 1895, p. 519, c. 462, § 1); in 1900 the firm procured its registration in the United States Patent Office under the Act of March 3, 1881, c. 138, 21 Stat. 502; in 1904 the Supreme Court of Massachusetts sustained their trade-mark right under the state law as against a concern that was selling medicinal preparations of the present petitioner under the designation of “Rexall remedies” (Regis v. Jaynes, 185 Massachusetts, 458); afterwards the firm established priority in the mark as against petitioner in a contested proceeding in the Patent Office; and subsequently, in the year 1911, petitioner purchased the business with the trade-mark right, and has carried it on in connection with its other business,’ which consists in the manufacture of medicinal preparations, and their, distribution and sale ■ through retail drug stores, known as “Rexall stores,” situate in the different States of the Union, four of them being in Louisville, Kentucky.

Meanwhile, about the year 1883, Theodore Rectanus, a druggist in Louisville, familiarly known as “Rex,” employed this word as a trade-mark for a medicinal prepara- . tion known as a “blood purifier.” He continued this use to a considerable extent in Louisville and vicinity, spending money in advertising and building up a trade, so that— *95 ( except for whatever effect might flow from Mrs', Regis.’ prior adoption of the word in Massachusetts, of which he was entirely ignorant — he was entitled to use the word as his trade-mark. In the year 1906 he sold his business, including the right to the use of the word, to respondent; and the use of the mark by him and afterwards by respondent was continuous from about the year 1883 .until the filing of the bill in the year 1912.

Petitioner’s first use of the word "Rex” in connection with the sale of drugs in Louisville or vicinity was in April, 1912; when two shipments of “Rex Dyspepsia Tablets,” aggregating 150 boxes and valued at $22.50, were sent to one of the “Rexall” stores in that city. Shortly after this the remedy was mentioned by name in local newspaper advertisements published by those stores. In' the previous September, petitioner shipped a trifling amount — five boxes — to a drug store in Franklin, Kentucky, approximately 120 miles distant from Louisville. There is nothing to. show that before this any customer in or near Kentucky had heard of the Regis remedy, with or without, the description “Rex,” or that this word ever possessed any meaning to the purchasing public in that State except as pointing to Rectanus and the Rectanus Company and their “blood purifier.” That it did and does convey the latter meaning in Louisville and vicinity is proved without dispute. Months before petitioner’s first shipment of its remedy to Kentucky, petitioner was distinctly notified (in June, 1911,) by one. of its Louisville distributors that respondent.'was. using the word “Rex” to designate its medicinal preparations, and that such use had been commenced by Mr. Rectanus as much as 16 or 17 years before that time.

There 'was nothing to sustain the allegation of .unfair competition, aside from the question of trade-mark infringement. As to this, both courts found, in substance, that the use of the same mark upon different but somewhat: *96 related preparations was carried on by the parties and their respective predecessors contemporaneously, but in widely separated localities, during the period in question— between 25 and 30 years — in perfect good faith, neither side having- any knowledge or notice of what was being done by the other. The District Court held that because the adoption of the mark by Mrs. Regis antedated its adoption by Rectanus, petitioner’s right to the exclusive use of the .word in connection .with medicinal preparations intended for dyspepsia and kindred diseases of the stomach and digestive organs must be sustained, but without accounting for profits or assessment of damages for unfair trade; citing McLean v. Fleming, 96 U. S. 245; Menendez v. Holt, 128 U. S. 514; Saxlehner v. Eisner & Mendelson Co., 179 U. S. 19, 39; Saxlehner v. Siegel-Cooper Co., 179 U. S. 42. The Circuit Court of Appeals held that in view of the fact that Rectanus had used the mark for a long period of years in entire -ignorance of Mrs. Regis ’ remedy. .or of. her trade-mark, had expended money in .making his mark well known, and had established a considerable-, though local business under it in Louisville and vicinity, while on thé other hand during the same long period Mrs. Regis had done nothing, either- by sales agencies or by advertising, to make her medicine or its mark known outside of the New England States, saving sporadic sales in territory adjacent to those States, and had made no effort whatever to extend the trade to Kentucky, she and her .successors were bound to know that, misled by their silence and inaction, others might act, as Rectanus and his successors did act, upon the assumption that the field was open, and therefore were estopped to ask for an injunction against the continued úse of the márk in Louisville and vicinity by the Rectanus Company.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pinkette Clothing, Inc. v. Cosmetic Warriors Ltd.
894 F.3d 1015 (Ninth Circuit, 2018)
Stark v. Diageo Chateau & Estate Wines Co.
907 F. Supp. 2d 1042 (N.D. California, 2012)
Dudley v. Healthsource Chiropractic, Inc.
883 F. Supp. 2d 377 (W.D. New York, 2012)
Burgess v. Gilman
475 F. Supp. 2d 1051 (D. Nevada, 2007)
De Beers LV Trademark Ltd. v. DeBeers Diamond Syndicate Inc.
440 F. Supp. 2d 249 (S.D. New York, 2006)
Almacenes Exito S.A. v. El Gallo Meat Market, Inc.
381 F. Supp. 2d 324 (S.D. New York, 2005)
Wood v. Apodaca
375 F. Supp. 2d 942 (N.D. California, 2005)
ITC Ltd. v. Punchgini, Inc.
373 F. Supp. 2d 275 (S.D. New York, 2005)
Argos v. ORTHOTEC LLC
304 F. Supp. 2d 591 (D. Delaware, 2004)
Midwest Guaranty Bank v. Guaranty Bank
270 F. Supp. 2d 900 (E.D. Michigan, 2003)
Joint Stock Society v. UDV North America, Inc.
53 F. Supp. 2d 692 (D. Delaware, 1999)
Popular Bank of Fla. v. BANCO POPULAR PUERTO RICO
9 F. Supp. 2d 1347 (S.D. Florida, 1998)
Bear U.S.A., Inc. v. Kim
993 F. Supp. 894 (S.D. New York, 1998)
Lobo Enterprises, Inc. v. Tunnel, Inc.
693 F. Supp. 71 (S.D. New York, 1988)
Hughes v. Design Look Inc.
693 F. Supp. 1500 (S.D. New York, 1988)
William Grant & Sons Ltd. v. European Beverages Co.
668 F. Supp. 1421 (C.D. California, 1987)

Cite This Page — Counsel Stack

Bluebook (online)
248 U.S. 90, 39 S. Ct. 48, 63 L. Ed. 141, 1918 U.S. LEXIS 1694, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-drug-co-v-theodore-rectanus-co-scotus-1918.